AGIOS PHARMACEUTICALS, INC. Operating Leases, Future Minimum Payments, Due in Four Years
AGIOS PHARMACEUTICALS, INC. (AGIO) had Operating Leases, Future Minimum Payments, Due in Four Years of $15.55 million as of 2018-12-31, per its 10-K filed 2020-02-19.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears · last filed 2020-02-19
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $15.55M.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $12.39M.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $9.75M.
- 2015-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $9.51M.
| Period end | Operating Leases, Future Minimum Payments, Due in Four Years |
|---|---|
| 2018-12-31 | $15.55M 10-K · filed 2020-02-19 |
| 2017-12-31 | $12.39M 10-K · filed 2018-02-14 |
| 2016-12-31 | $9.75M 10-K · filed 2017-02-16 |
| 2015-12-31 | $9.51M 10-K · filed 2016-02-26 |
| 2014-12-31 | $7.00M 10-K · filed 2015-02-24 |
| 2014-09-30 | $4.41M 10-Q · filed 2014-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |